10 days ago
NBIX
AnalystsJeffrey HungJeffrey Hung's Stock Forecasts
AnalystsJeffrey Hung
Sectors:
Analyst Ranking
Top 10%
#465 out of 5081 analysts
Average Return
+12.2%
Win Rate
58%73 out of 125
Risk vs Reward
Poor
Good
Jeffrey Hung's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Myokardia IncMYOK | +314.95% | $53.26 | $221.00 | 2020-04-15 - 2020-10-06 | Strong Buy |
Cytokinetics IncCYTK | +182.40% | $33.19 | $93.73 | 2023-08-04 - 2024-01-05 | Strong Buy |
Cytokinetics IncCYTK | +151.83% | $37.22 | $93.73 | 2023-06-22 - 2024-01-05 | Strong Buy |
Contineum Therapeutics IncCTNM | +149.43% | $4.37 | $10.90 | 2025-05-19 - 2025-10-29 | Strong Buy |
Rhythm Pharmaceuticals IncRYTM | +124.24% | $50.79 | $113.89 | 2025-03-07 - 2025-10-29 | Strong Buy |
Jeffrey Hung Analyst Color
Get additional color on Jeffrey Hung's coverage of popular stocks
10 days ago
JAZZ
14 days ago
RYTM
a month ago
RYTM
a month ago
JAZZ
a month ago
CGON
2 months ago
JAZZ
3 months ago
RYTM
3 months ago
NBIX
3 months ago
FOLD
4 months ago
CGON
8 months ago
PTCT
8 months ago
JAZZ
9 months ago
NBIX
a year ago
PTCT
a year ago
ITCI
a year ago
CNTA
a year ago
NBIX
2 years ago
RYTM
2 years ago
FOLD
2 years ago
BLUE
Jeffrey Hung's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neurocrine Biosciences IncNBIX | 15 | Strong Buy | $168.00 | +21.72% | Maintains | 10 days ago |
Jazz Pharmaceuticals PLCJAZZ | 11 | Strong Buy | $180.00 | +32.62% | Maintains | 10 days ago |
Rhythm Pharmaceuticals IncRYTM | 13 | Strong Buy | $129.00 | +13.27% | Maintains | 14 days ago |
Crinetics Pharmaceuticals IncCRNX | 3 | Strong Buy | $77.00 | +79.49% | Maintains | a month ago |
Cg Oncology IncCGON | 5 | Strong Buy | $79.00 | +83.81% | Maintains | a month ago |
Engene Holdings IncENGN | 4 | Strong Buy | $18.00 | +147.70% | Maintains | 2 months ago |
Ptc Therapeutics IncPTCT | 13 | Strong Buy | $71.00 | +5.42% | Maintains | 2 months ago |
Cullinan Therapeutics IncCGEM | 6 | Strong Buy | $28.00 | +264.11% | Maintains | 2 months ago |
Contineum Therapeutics IncCTNM | 4 | Strong Buy | $21.00 | +92.66% | Maintains | 2 months ago |
Erasca IncERAS | 4 | Hold | $2.00 | -15.25% | Downgrades | 2 months ago |
Bicycle Therapeutics PLCBCYC | 6 | Hold | $13.00 | +58.92% | Maintains | 3 months ago |
Amicus Therapeutics IncFOLD | 5 | Strong Buy | $108.00 | +1,113.48% | Upgrades | 3 months ago |
Ultragenyx Pharmaceutical IncRARE | 8 | Strong Buy | $55.00 | +59.01% | Maintains | 4 months ago |
Acadia Pharmaceuticals IncACAD | 20 | Hold | $24.00 | +6.52% | Maintains | 5 months ago |
Disc Medicine IncIRON | 6 | Strong Buy | $85.00 | 0.00% | Assumes | 8 months ago |
Centessa Pharmaceuticals PLCCNTA | 2 | Strong Buy | $27.00 | +12.59% | Assumes | 8 months ago |
Bioage Labs IncBIOA | 2 | Strong Sell | $5.00 | -34.90% | Assumes | 8 months ago |
Cytokinetics IncCYTK | 7 | Strong Buy | $67.00 | +8.08% | Upgrades | 9 months ago |
Intra Cellular Therapies IncITCI | 5 | Strong Buy | $95.00 | N/A | Maintains | a year ago |
Cervomed IncCRVO | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Karuna Therapeutics IncKRTX | 3 | Hold | $330.00 | N/A | Downgrades | 2 years ago |
Prelude Therapeutics IncPRLD | 6 | Strong Sell | $4.00 | N/A | Downgrades | 2 years ago |
Vigil Neuroscience IncVIGL | 1 | Strong Sell | $4.00 | N/A | Downgrades | 2 years ago |
Invivyd IncIVVD | 1 | Hold | $4.00 | N/A | Upgrades | 2 years ago |
Bluebird Bio IncBLUE | 1 | Hold | $140.00 | N/A | Upgrades | 2 years ago |
Immuneering CorpIMRX | 3 | Hold | $14.00 | N/A | Maintains | 2 years ago |
Esperion Therapeutics IncESPR | 7 | Hold | $3.00 | N/A | Maintains | 3 years ago |
Repare Therapeutics IncRPTX | 5 | Hold | $14.00 | N/A | Maintains | 3 years ago |
Lenz Therapeutics IncLENZ | 4 | Hold | $3.00 | N/A | Maintains | 3 years ago |
Cyteir Therapeutics IncCYTT | 3 | Strong Sell | $2.00 | N/A | Downgrades | 3 years ago |
Celularity IncCELU | 3 | Strong Sell | $10.00 | N/A | Downgrades | 3 years ago |
Cincor Pharma IncCINC | 6 | Hold | $30.00 | N/A | Maintains | 3 years ago |
Exelixis IncEXEL | 2 | Hold | $22.00 | N/A | Maintains | 3 years ago |
Rubius Therapeutics IncRUBY | 3 | Hold | $1.50 | N/A | Maintains | 3 years ago |
Evofem Biosciences IncEVFM | 6 | Strong Sell | $0.75 | N/A | Maintains | 3 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Hold | $146.00 | N/A | Maintains | 4 years ago |
Acceleron Pharma IncXLRN | 3 | Hold | $180.00 | N/A | Downgrades | 4 years ago |
Aprea Therapeutics IncAPRE | 5 | Strong Sell | $60.00 | N/A | Downgrades | 4 years ago |
Voyager Therapeutics IncVYGR | 2 | Hold | $7.00 | N/A | Maintains | 5 years ago |
Myokardia IncMYOK | 2 | Hold | $225.00 | N/A | Downgrades | 5 years ago |
Nextcure IncNXTC | 6 | Strong Buy | $648.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.